id
name
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2024-03-19 16:20:49
expired found date
-
created at
2024-06-07 07:05:52
updated at
2025-12-30 12:04:44
length
13
crc
27673
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
74966
mp size raw text
4701
mp inner links count
1
mp inner links status
20 (imported)
title
AKEEGA™ (niraparib/abiraterone acetate) HCP
description
AKEEGA™, the first and only dual action tablet combining PARB inhibition and novel hormonal therapy for your adult patients. See full Safety & Prescribing Information.
site name
author
updated
2025-12-18 11:41:58
raw text
AKEEGA™ (niraparib/abiraterone acetate) Healthcare Professional Website For Healthcare Professionals Patient Website Important Safety Information Medical Inquiries Prescribing Information Stay Informed For Heathcare Professionals BRCA m in Prostate Cancer Efficacy Safety & Tolerability Dosing Access & Support Find a Janssen Specialist Patient Website Important Safety Information Medical Inquiries Prescribing Information Stay Informed Find a Janssen Specialist IT'S A CLEAR TREATMENT PATH WITH AKEEGA™, IT'S A CLEAR TREATMENT PATH WITH AKEEGA™, THE ONLY FDA-APPROVED DUAL ACTION TABLET FOR BRCA + mCRPC AKEEGA™ is the first-and-only FDA-approved dual action tablet combining PARP inhibition and novel hormonal therapy to provide precision medicine for patients with BRCA + mCRPC. 1 Niraparib and abiraterone acetate (AKEEGA™) is a recommended treatment option by the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ® ) for...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
index version
2025110801
spam phrases
3
text nonlatin
0
text cyrillic
0
text characters
3669
text words
671
text unique words
309
text lines
120
text sentences
26
text paragraphs
7
text words per sentence
25
text matched phrases
9
text matched dictionaries
3
links self subdomains
0
links other subdomains
0
links other domains
10 - akeega.com, janssenscience.com, janssenlabels.com, janssen.com
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
0
links ext klim
0
links ext generic
0
dol status
0
dol updated
2025-12-18 11:41:58
rss path
rss status
3 (priority 3 already searched, no matches found)
rss found date
-
rss size orig
0
rss items
0
rss spam phrases
0
rss detected language
0 (awaiting analysis)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
30 (processing completed, results pushed to table crawler_sitemaps.ext_domain_sitemap_lists)
sitemap review version
1
sitemap urls count
11
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2024-03-24 16:08:04
sitemap process date
2024-11-08 05:14:22
sitemap first import date
-
sitemap last import date
-